在TAVR期间冠状动脉阻塞的高风险,如何避免?
Jose R Gayosso-Ortíz1,2, Juan F Garcia-Garcia1,2, Jose Alfredo Merino-Rajme1
1Interventional cardiology service, National Medical Center, November 20, Mexico City, Mexico.
Journal of cardiothoracic surgery
|March 20, 2024
概括
在跨导管大动脉置换 (TAVR) 期间冠状动脉阻塞是一个严重的风险. 一种烟支架技术成功地治疗了一名患者的左主冠状动脉阻塞,突出了其预防潜力.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 结构性心脏病 结构性心脏病
背景情况:
- 冠状动脉阻塞是跨导管大动脉置换 (TAVR) 后的一个关键并发症,往往导致高死亡率.
- 预测因素包括骨距离,化和鼻接近,需要预防和治疗策略.
研究的目的:
- 报告TAVR期间冠状动脉阻塞成功管理的案例.
- 评估烟支架技术在预防TAVR相关冠状动脉阻塞方面的有效性.
主要方法:
- 一名患有严重大动脉狭窄的84岁男性接受了TAVR.
- 在门部署期间,由于左主冠状动脉 (LMCA) 阻塞,发生了血液动力学不稳定.
- 血管内成像显示,由排位造成的骨阻塞,用烟支架技术进行治疗.
主要成果:
- 烟支架技术成功解决了LMCA阻塞.
- 患者的血液动力学不稳定性在干预后得到稳定.
- 在治理冠状动脉阻塞后,手术成功完成.
结论:
- 严重的大动脉化和低卧的左冠状动脉骨是TAVR期间骨阻塞的危险因素.
- 在TAVR之前临时支架可能是高风险患者的安全有效的预防策略.
- 这种方法可以提高TAVR程序成功率.
相关概念视频
Coronary Artery Disease IV: Preventive Measures
891
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891
Coronary Artery Disease V: Interprofessional Care
450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450


